Probmet is a precision oncology therapeutics company developing treatments for cancer.
Probmet has raised $548K in total funding. The most recent round was Convertible Note. The last funding was announced in March 2022.
Probmet's investors include BioInnovation Institute.
Probmet is headquartered in Copenhagen, Denmark.
Probmet is a precision oncology therapeutics company developing treatments for cancer.
Probmet is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Probmet — Funding & Investors." VCBacked, March 15, 2022, https://www.vcbacked.co/company/probmet. Accessed September 30, 2026.
VCBacked. (2022). Probmet — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/probmet
{{cite web |title=Probmet — Funding & Investors |url=https://www.vcbacked.co/company/probmet |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated